Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Do we need an early unfavorable (intermediate) stage of Hodgkin's lymphoma?

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Incidence and survival of hypopharyngeal cancer: a Danish Nation-Wide Study from 1980 to 2014

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Intratumor heterogeneity of PD-L1 expression in head and neck squamous cell carcinoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. On the relation between improved loco-regional control and disease-free survival in head-and-neck cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
The outcome of patients who have early unfavorable or intermediate-stage Hodgkin's lymphoma has greatly improved. The increasing efficacy of chemotherapy and late toxic effects of wide-field radiotherapy justify the careful testing of the new involved-node radiotherapy principle in the combined-modality approach. For the purpose of tailoring treatment to the individual patient we need more accurate measures, preferably predictive factors that may tell us how the individual patient should be treated. The result of an early positron emission tomography scan with fluorodeoxyglucose may well become the major new treatment-related guidance for an individually tailored treatment approach.
Original languageEnglish
JournalHematology / Oncology Clinics of North America
Volume21
Issue number5
Pages (from-to)881-96
Number of pages16
ISSN0889-8588
DOIs
Publication statusPublished - 1 Oct 2007

ID: 32265562